Hims & Hers Health (NYSE:HIMS) Trading 7.5% Higher - Still a Buy?

Shares of Hims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) shot up 7.5% during trading on Monday . The stock traded as high as $51.05 and last traded at $51.48. 12,376,623 shares traded hands during trading, a decline of 48% from the average session volume of 23,861,356 shares. The stock had previously closed at $47.89.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on HIMS shares. Truist Financial set a $45.00 price objective on Hims & Hers Health in a research report on Tuesday, June 24th. UBS Group set a $30.00 price objective on Hims & Hers Health in a research report on Monday, June 23rd. Deutsche Bank Aktiengesellschaft reissued a "hold" rating on shares of Hims & Hers Health in a research report on Wednesday, May 7th. Citigroup reissued a "sell" rating on shares of Hims & Hers Health in a research report on Monday, June 23rd. Finally, Bank of America raised their target price on Hims & Hers Health from $22.00 to $26.00 and gave the stock an "underperform" rating in a research report on Tuesday, April 29th. Three analysts have rated the stock with a sell rating, nine have given a hold rating and two have issued a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Hold" and a consensus price target of $39.58.

Hims & Hers Health Stock Up 8.5%

The company has a market capitalization of $11.63 billion, a P/E ratio of 75.33, a PEG ratio of 1.76 and a beta of 2.02. The stock has a fifty day simple moving average of $53.88 and a 200-day simple moving average of $41.31.

Hims & Hers Health (NYSE:HIMS - Get Free Report) last issued its quarterly earnings data on Monday, May 5th. The company reported $0.20 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.12 by $0.08. The company had revenue of $586.01 million during the quarter, compared to analysts' expectations of $535.21 million. Hims & Hers Health had a return on equity of 22.75% and a net margin of 9.24%. The business's revenue was up 110.7% on a year-over-year basis. During the same period last year, the business earned $0.05 earnings per share. Analysts predict that Hims & Hers Health, Inc. will post 0.29 earnings per share for the current fiscal year.

Insider Transactions at Hims & Hers Health

In other news, insider Irene Becklund sold 8,485 shares of the business's stock in a transaction dated Tuesday, June 17th. The stock was sold at an average price of $59.75, for a total transaction of $506,978.75. Following the completion of the transaction, the insider directly owned 712 shares in the company, valued at approximately $42,542. The trade was a 92.26% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Michael Chi sold 17,102 shares of the business's stock in a transaction that occurred on Tuesday, June 17th. The shares were sold at an average price of $59.75, for a total value of $1,021,844.50. Following the completion of the sale, the insider owned 278,654 shares in the company, valued at $16,649,576.50. The trade was a 5.78% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 667,014 shares of company stock valued at $34,394,653. 17.71% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the company. US Bancorp DE lifted its stake in Hims & Hers Health by 346.7% in the fourth quarter. US Bancorp DE now owns 1,943 shares of the company's stock valued at $47,000 after buying an additional 1,508 shares during the period. Steward Partners Investment Advisory LLC bought a new stake in shares of Hims & Hers Health in the 4th quarter worth approximately $67,000. Victory Capital Management Inc. grew its stake in shares of Hims & Hers Health by 1.9% during the 4th quarter. Victory Capital Management Inc. now owns 52,579 shares of the company's stock worth $1,271,000 after acquiring an additional 1,002 shares during the period. Raymond James Financial Inc. bought a new position in shares of Hims & Hers Health during the 4th quarter worth $18,048,000. Finally, PNC Financial Services Group Inc. grew its stake in shares of Hims & Hers Health by 51.9% during the 4th quarter. PNC Financial Services Group Inc. now owns 17,225 shares of the company's stock worth $417,000 after acquiring an additional 5,885 shares during the period. Institutional investors own 63.52% of the company's stock.

Hims & Hers Health Company Profile

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.